NorthWest Biotherapeutics Inc (NWBO)

[sukus]

BlackRock name surfaced again. BlackRock is one of large institution holders of Amyris stock that I owned. The name appears in that list proves my point that a big firm like BlackRock or Vanguard or Renaissance or JP Morgan is very much interested in the potential of that small or tiny company. And especially true if this small innovative company can disrupt the landscape. I believe NWBO has the potential to disrupt the landscape of cancer treatment with spectacular safety and great quality of life and meaningful life extension. This company worth will be validated. Don’t be surprised those names will show up in the list as top holders of NWBO.